Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 1.61B | 1.23B | 1.44B | 1.45B | 958.25M |
Gross Profit | 119.86M | 114.83M | 139.32M | 137.24M | 162.04M |
EBITDA | -119.68M | 104.25M | 229.03M | 371.59M | 171.05M |
Net Income | -216.01M | -38.43M | 154.34M | 274.99M | 221.38M |
Balance Sheet | |||||
Total Assets | 6.23B | 6.16B | 6.72B | 8.13B | 6.52B |
Cash, Cash Equivalents and Short-Term Investments | 441.75M | 399.89M | 602.87M | 706.83M | 246.46M |
Total Debt | 1.89B | 1.53B | 1.80B | 3.19B | 1.68B |
Total Liabilities | 2.46B | 2.09B | 2.50B | 3.99B | 2.60B |
Stockholders Equity | 3.77B | 4.07B | 4.22B | 4.14B | 3.92B |
Cash Flow | |||||
Free Cash Flow | -215.90M | -171.54M | -179.80M | -851.71M | -328.78M |
Operating Cash Flow | -202.28M | -142.63M | -178.52M | -844.41M | -313.34M |
Investing Cash Flow | -18.75M | 300.23M | 1.21B | 764.88M | -1.54B |
Financing Cash Flow | 265.56M | -367.45M | -1.13B | 539.78M | 1.23B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | HK$2.66B | 13.69 | 5.58% | 2.90% | -19.93% | -43.35% | |
69 Neutral | $79.42B | 20.89 | 2.17% | 1.73% | -30.38% | -43.73% | |
63 Neutral | HK$11.02B | ― | -3.12% | 6.78% | 2.20% | -327.14% | |
62 Neutral | HK$29.61B | 36.64 | 0.76% | 9.31% | 50.11% | -75.09% | |
58 Neutral | HK$14.16B | 4.53 | -3.01% | 6.82% | 3.67% | -54.16% | |
50 Neutral | $14.09B | ― | -10.34% | 8.93% | -56.64% | -3398.20% | |
43 Neutral | HK$295.10M | ― | -8.17% | 24.00% | 46.07% | -338.97% |